| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 |
| filingDate |
2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006515869-A |
| titleOfInvention |
Method for obtaining 17α-acetoxy-11β- (4-N, N-dimethylaminophenyl) -19-norpregna-4,9-diene-3,20-dione |
| abstract |
The process according to the invention comprises (a) 17α-acetoxy-11β- (4-N, N-dimethylaminophenyl) -19-norpregna-4,9-diene-3,20 by dissolution in isopropanol and subsequent crystallization. -Crystals of dione (VA-2914) isopropanol hemisorbate are formed; (b) crystals of VA-2914 isopropanol hemisorbate are separated; (c) the VA-2914 isopropanol hemisorbate is converted to VA-2914 Comprising doing. Compound VA-2914 is a steroid with antiprogesterone and antiglucocorticoid activity useful for gynecological indications for treatment and contraception, and for the treatment of Cushing's syndrome and glaucoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015120711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014050105-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014050107-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014050106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012523446-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006519255-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015531340-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016188232-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011510949-A |
| priorityDate |
2003-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |